Autopsy report · NCT02961283

Study of ASN003 in Subjects With Advanced Solid Tumors

“reformulation”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 4 months before it stopped.
• 24 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Asana BioSciences

Sponsor type

Industry

Conditions

Neoplasms; Melanoma; Colorectal Neoplasm; Carcinoma, Non-small Cell Lung

Interventions

ASN003 ascending doses; ASN003 MTD

Participants

24

Sites

5

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.